<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1038/s41598-019-52260-z</dc:identifier><dc:language>eng</dc:language><dc:creator>Montero-Marin, Jesús</dc:creator><dc:creator>Andrés-Rodríguez, Laura</dc:creator><dc:creator>Tops, Mattie</dc:creator><dc:creator>Luciano, Juan V.</dc:creator><dc:creator>Navarro-Gil, Mayte</dc:creator><dc:creator>Feliu-Soler, Albert</dc:creator><dc:creator>López-del-Hoyo, Yolanda</dc:creator><dc:creator>Garcia-Campayo, Javier</dc:creator><dc:title>Effects of attachment-based compassion therapy (ABCT) on brain-derived neurotrophic factor and low-grade inflammation among fibromyalgia patients: A randomized controlled trial</dc:title><dc:identifier>ART-2019-114748</dc:identifier><dc:description>Fibromyalgia (FM) is a disabling syndrome characterized by chronic pain associated with fatigue. Its pathogenesis is unknown, but alterations in central sensitization, involving an imbalance of brain-derived neurotrophic factor (BDNF) and inflammatory biomarkers, appear to be implicated. The aim of this study was to evaluate the impact of attachment-based compassion therapy (ABCT) on levels of BDNF, the inflammatory markers TNF-a, IL-6, IL-10, and the C-reactive protein (CRP), analysing whether biomarkers play a mediating/moderating role in improvements in FM functional status. Thirty-four female patients with FM participated in a RCT and were assigned to ABCT or relaxation therapy. Blood extractions were conducted at baseline and post-intervention, with self-report assessments of functional status (FIQ) at baseline, post-intervention and 3-month follow-up. A pro-inflammatory composite was obtained by summing up IL-6, TNF-a and CRP normalized values. Non-parametric tests, analysis of variance and regression models were used to evaluate treatment and mediation/moderation. Compared to relaxation therapy, ABCT showed significant improvements in FIQ and decreases in BDNF, CRP, and pro-inflammatory composite. Changes in BDNF had a mediating role in FIQ. ABCT seems to reduce BDNF and appears to have anti-inflammatory effects in FM patients. Reductions in BDNF could be a mechanism of FM functional status improvement.</dc:description><dc:date>2019</dc:date><dc:source>http://zaguan.unizar.es/record/86231</dc:source><dc:doi>10.1038/s41598-019-52260-z</dc:doi><dc:identifier>http://zaguan.unizar.es/record/86231</dc:identifier><dc:identifier>oai:zaguan.unizar.es:86231</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B17-17R</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/ISCIII/CD16-00147</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/ISCIII-MINECO-FEDER/RD16-0007-0005</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/ISCIII/RD16-0007-0012</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MICINN/ISCIII-RD06-0018-0017</dc:relation><dc:identifier.citation>Scientific Reports 9, 1 (2019), 15639 [14 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>